Neutralizing antibodies bind at or near the active site of the drug molecule and neutralize its functional activity.
Brought to you by
Watch On Demand
Neutralizing antibodies bind at or near the active site of the drug molecule and neutralize its functional activity. For therapeutic neutralizing antibodies, their functional activities are evaluated from screening, research and development, production and product release.
Due to advances in basic theory and technology, these methods are updated rapidly.
This webinar discusses the approaches used to screen for SARS-CoV-2 (2019-nCoV) neutralizing antibodies and evaluate their bioactivity in vitro.
By attending this webinar, you will learn:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks, All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy